跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
therapeutic proteins
首页
药物
therapeutic proteins
therapeutic proteins
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
THERAPEUTIC FUSION PROTEINS
EP 4025237 A1
申请人: NOVARTIS AG
优先权: 2019
CN
EP
US
WO
16 件公开
US 10081803 B2
申请人: CHADDOCK JOHN
优先权: 2011
US
3 件公开
RECOMBINANT PROTEINS AND THEIR THERAPEUTIC USES
EP 2782598 B1
申请人: IN3BIO LTD
优先权: 2011
CN
EP
US
WO
14 件公开
Targeted therapeutic proteins
US 7560424 B2
申请人: ZYSTOR THERAPEUTICS INC
优先权: 2002
US
13 件公开
US 7629309 B2
申请人: ZYSTOR THERAPEUTICS INC
优先权: 2004
US
6 件公开
US 2004005309 A1
申请人: SYMBIONTICS INC
优先权: 2002
US
EP 1514106 A4
申请人: ZYSTOR THERAPEUTICS INC
优先权: 2003
EP
Therapeutic agents comprising pro-apoptotic proteins
US 7101977 B2
申请人: RES DEV FOUNDATION
优先权: 2002
US
10 件公开
A METHOD OF PURIFYING THERAPEUTIC PROTEINS
EP 2928905 A4
申请人: CSL BEHRING GMBH
优先权: 2012
CN
EP
US
WO
9 件公开
US 2015366947 A1
申请人: CSL LTD
优先权: 2013
US
Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof
US 9376480 B2
申请人: BIOMARIN PHARM INC
优先权: 2013
US
9 件公开
THERAPEUTIC INTERFERON ALPHA 1 PROTEINS
EP 3946410 A4
申请人: ORIONIS BIOSCIENCES INC
优先权: 2019
CN
EP
US
WO
8 件公开
SCAFFOLD PROTEINS AND THERAPEUTIC NANOCONJUGATES BASED ON NIDOGEN
EP 3842452 A1
申请人: UNIV AUTÒNOMA DE BARCELONA
优先权: 2019
CN
EP
US
WO
7 件公开
THERAPEUTIC DLL4 BINDING PROTEINS
CN 105131112 A
申请人: ABBOTT LAB
优先权: 2009
CN
EP
US
7 件公开
EP 3072904 A1
申请人: ABBVIE INC
优先权: 2010
EP
US
5 件公开
Bi-specific annexin A5/IGF-1 proteins and methods of use thereof to promote regeneration and survival of tissue
US 10040840 B2
申请人: SILVER CREEK PHARMACEUTICALS INC
优先权: 2015
CN
US
7 件公开
第 1 / 9 页
上一页
下一页
药物
反馈